This lack of sufficiency can be seen in potential CeD patients, who carry HLA-DQ2 or HLA-DQ8 and display adaptive immune responses against gluten (proxied by anti-TG2 and anti-endomysium antibodies) but lack villous atrophy (6, 34). The gene discussed is TGM2; the disease is cranioectodermal dysplasia.